Platform Overview: Introduction to INDUCE-seq®, a PCR-free method for genome-wide mapping of double-strand DNA breaks in days, not months
Time: 2:30 pm
day: Conference Day One
Details:
- Therapeutic Development: Data on confirming gene editing efficiency via on-target break detection
- Applications in iPSC and T-cell therapies: Evaluation of base editor tools using INDUCE-seq®
- Preclinical Safety Assessment:
- Results from the NIST genome editing program and collaboration with HESI
- Data from studies with the Innovative Genomics Institute (IGI) supporting Gene Editing INDs
- Guide RNA Screening: Progress on SafeGuide AI, a predictive tool to differentiate safe vs. high-risk gRNA designs
